Owner NEUROCRINE BIOSCIENCES, INC.

Inventors MARINKOVIC, Dragan; LANIER, Marion, C.; TRAN, Joe, Ahn; ARELLANO, Melissa; PARKER, Jessica; NELSON, Jodie; CHEN, Chen; CHEN, Caroline; JIANG, Wanglong; WHITE, Nicole; TUCCI, Fabio, C.; PONTILLO, Joseph

Pub. Number AU-A-2003230367

PCT Number PCT/US03/14628

PCT Pub. Number WO2003/094918

Priority 60/379,517 10.05.02 US; 60/422,272 29.10.02 US

Filing date 9 May 2003

Wipo publication date 11 November 2003

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 307/52 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 207/34 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/60 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/62 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 265/30 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 233/02 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 207/26 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 317/58 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 003/04 Drugs for disorders of the metabolism

C07D 333/20 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 217/26 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 295/18 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 213/74 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 211/52 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 207/16 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/32 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 277/30 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/16 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom